Hong Seng Consolidated Bhd
KLSE:HONGSENG
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.01
0.03
|
| Price Target |
|
We'll email you a reminder when the closing price reaches MYR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Hong Seng Consolidated Bhd
Revenue
Hong Seng Consolidated Bhd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hong Seng Consolidated Bhd
KLSE:HONGSENG
|
Revenue
myr18.5m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-6%
|
|
|
O
|
Optimax Holdings Bhd
KLSE:OPTIMAX
|
Revenue
myr114m
|
CAGR 3-Years
25%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
T
|
TMC Life Sciences Bhd
KLSE:TMCLIFE
|
Revenue
myr346.4m
|
CAGR 3-Years
20%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
|
D
|
DC Healthcare Holdings Bhd
KLSE:DCHCARE
|
Revenue
myr67.7m
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hong Seng Consolidated Bhd
Glance View
Hong Seng Consolidated Bhd.is an investment holding company, which engages in the provision of financing solutions from directory service and financial services business. The company is headquartered in Petaling Jaya, Selangor. The company went IPO on 2004-04-20. The firm's business includes gloves manufacturing, healthcare, financial services, and search and advertising. The healthcare business focuses on offering end-to-end medical supply chain management solutions. The firm is involved in managing the end-to-end supply chain of COVID-19 testing processes known as HealthChain, which encompasses front-facing and back-end processes, physical logistics, digital healthcare platform, laboratory facilities and research and development services, as well as the provision of medical and healthcare supplies. The financial services business includes the hire purchase and money lending activities. The search and advertising business focuses on providing multi-channel marketing solutions and business data licensing. The firm specializes in developing business platforms, providing business data and marketing services to small medium enterprises and corporate.
See Also
What is Hong Seng Consolidated Bhd's Revenue?
Revenue
18.5m
MYR
Based on the financial report for Jun 30, 2024, Hong Seng Consolidated Bhd's Revenue amounts to 18.5m MYR.
What is Hong Seng Consolidated Bhd's Revenue growth rate?
Revenue CAGR 10Y
-6%
Over the last year, the Revenue growth was 110%. The average annual Revenue growth rates for Hong Seng Consolidated Bhd have been -41% over the past three years , 14% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
